OBJECTIVE: Measuring sexually transmitted infections (STIs) and sexual practices in injection drug users (IDUs) and their regular sex partners. GOAL: Informing HIV intervention programs. DESIGN: Cross-sectional. RESULTS: One percent IDUs and 2% of their regular female sex partners were syphilis infected; 40% (84/211) and 38% respectively (81/211) were infected with HSV-2. 30% IDUs and 5% of their female regular sex partners were HIV positive. Serodiscordant results for syphilis and HSV-2 were noticed. Women having first sex at age<or=17 years and those who had HIV-positive IDUs as their male sexual partner had two times the odds of having any non-HIV-STI (OR 2.04; 95% CI 1.1-3.8; P=0.02 and OR 2.38; 95% CI 1.1-5.1; P=0.02 respectively) in a multivariate model. Women>or=38 years had seven times the odds of having any non-HIV-STI. CONCLUSION: Reaching out to IDUs and their female regular sex partners with modified STI management guideline and promoting women-controlled safer sex measures are needed harm-reduction measures.
OBJECTIVE: Measuring sexually transmitted infections (STIs) and sexual practices in injection drug users (IDUs) and their regular sex partners. GOAL: Informing HIV intervention programs. DESIGN: Cross-sectional. RESULTS: One percent IDUs and 2% of their regular female sex partners were syphilis infected; 40% (84/211) and 38% respectively (81/211) were infected with HSV-2. 30% IDUs and 5% of their female regular sex partners were HIV positive. Serodiscordant results for syphilis and HSV-2 were noticed. Women having first sex at age<or=17 years and those who had HIV-positive IDUs as their male sexual partner had two times the odds of having any non-HIV-STI (OR 2.04; 95% CI 1.1-3.8; P=0.02 and OR 2.38; 95% CI 1.1-5.1; P=0.02 respectively) in a multivariate model. Women>or=38 years had seven times the odds of having any non-HIV-STI. CONCLUSION: Reaching out to IDUs and their female regular sex partners with modified STI management guideline and promoting women-controlled safer sex measures are needed harm-reduction measures.
Authors: Sunil S Solomon; Shruti H Mehta; Amanda Latimore; Aylur K Srikrishnan; David D Celentano Journal: J Int AIDS Soc Date: 2010-06-23 Impact factor: 5.396
Authors: N Kumarasamy; P Balakrishnan; K K Venkatesh; A K Srikrishnan; A J Cecelia; E Thamburaj; S Solomon; K H Mayer Journal: AIDS Patient Care STDS Date: 2008-08 Impact factor: 5.078
Authors: Lara S Coffin; Ashley Newberry; Holly Hagan; Charles M Cleland; Don C Des Jarlais; David C Perlman Journal: Int J Drug Policy Date: 2009-04-09
Authors: Sunil S Solomon; Aylur K Srikrishnan; David D Celentano; Sethulakshmi C Johnson; Canjeevaram K Vasudevan; Kailapuri G Murugavel; Santhanam Anand; M Suresh Kumar; Suniti Solomon; Shruti H Mehta Journal: BMC Public Health Date: 2011-01-16 Impact factor: 3.295